Connection

Pankaj Malhotra to Multiple Myeloma

This is a "connection" page, showing publications Pankaj Malhotra has written about Multiple Myeloma.
Connection Strength

1.423
  1. Real world experience with "generic" pomalidomide in relapsed refractory multiple myeloma. Leuk Lymphoma. 2019 04; 60(4):1102-1104.
    View in: PubMed
    Score: 0.373
  2. AYA-Myeloma: Real-World, Single-Center Experience Over Last 5 Years. J Adolesc Young Adult Oncol. 2018 02; 7(1):120-124.
    View in: PubMed
    Score: 0.345
  3. Plasma cells with hairy projections and Auer rod-like inclusions in a patient with multiple myeloma. BMJ Case Rep. 2017 Aug 03; 2017.
    View in: PubMed
    Score: 0.344
  4. Impact of frailty, melphalan pharmacokinetics, and pharmacogenetics on outcomes post autologous hematopoietic cell transplantation for multiple myeloma. Bone Marrow Transplant. 2019 12; 54(12):2088-2095.
    View in: PubMed
    Score: 0.099
  5. Recent advances in the management of multiple myeloma: clinical impact based on resource-stratification. Consensus statement of the Asian Myeloma Network at the 16th international myeloma workshop. Leuk Lymphoma. 2018 10; 59(10):2305-2317.
    View in: PubMed
    Score: 0.089
  6. Multiple myeloma or lymphoma? The increasing role of flow cytometry and serum-free light chain assay. Indian J Pathol Microbiol. 2018 Jan-Mar; 61(1):149-150.
    View in: PubMed
    Score: 0.088
  7. Evaluation of Bortezomib-Induced Neuropathy Using Total Neuropathy Score (Reduced and Clinical Versions) and NCI CTCAE v4.0 in Newly Diagnosed Patients With Multiple Myeloma Receiving Bortezomib-Based Induction. Clin Lymphoma Myeloma Leuk. 2017 08; 17(8):513-519.e1.
    View in: PubMed
    Score: 0.085
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.